Oelschlager Kristen M sold $178K of CSTL
Oelschlager Kristen M (Chief Operating Officer) sold 8,587 shares of CASTLE BIOSCIENCES INC (CSTL) at $20.71 ($0.18M total) on 2026-06-16 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale size (8,587 shares), price ($20.71), and post-transaction holdings (30,460 shares) under a pre-arranged 10b5-1 plan.
Market read
Traders may briefly reassess sentiment around CSTL due to disclosed insider selling, but the 10b5-1 framing reduces the signal strength.
What to watch
The article does not state whether the sale was part of a broader pattern, tax planning, or option exercise activity beyond the single transaction, limiting inference.
Background
The article is an SEC Form 4 insider transaction disclosure for CASTLE BIOSCIENCES, reported by the COO.
Ticker impact
CASTLE BIOSCIENCES COO sold 8,587 shares at $20.71 via an open-market sale under a pre-arranged 10b5-1 plan, per Form 4.
Likely minimal price impact; any effect would be short-lived unless accompanied by other fundamental news.
The filing is a primary-source Form 4 and provides exact transaction details, but it is explicitly under a pre-arranged 10b5-1 plan and does not include new company fundamentals.
Market effects
No sector-level implications; this is an isolated insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can still coincide with management’s near-term risk assessment, so traders may treat it as a mild bearish sentiment input.
Key entities
- issuerCASTLE BIOSCIENCES INC
Subject of the Form 4 insider transaction disclosure.
- insiderOelschlager Kristen M
Chief Operating Officer who sold shares.
